Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin in patients with Attention-Deficit/Hyperactivity Disorder (ADHD)
IRCT2017050433810N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of curcumin in attention deficit hyperactivity disorder (ADHD), sponsored by Mashhad University of Medical Sciences. Started May 2017; status: completed.
02
Drugs
curcumin
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT2017050433810N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017050433810N1.